期刊文献+

非酒精性脂肪性肝病与心房颤动关系的研究进展

Research progress on the relationship between nonalcoholic fatty liver disease and atrial fibrillation
在线阅读 下载PDF
导出
摘要 非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)和心房颤动(atrial fibrillation,AF)是常见的慢性非传染性疾病,发病率呈上升趋势。多项研究证实,NAFLD是AF发病的独立危险因素。然而,由于混杂因素的普遍存在,NAFLD在AF发展中的独立致病作用仍需进一步研究。NAFLD引起AF的机制包括心外膜脂肪组织(epicardial adipose tissue,EAT)增加、心肌重构、脂联素水平降低等,以及促进炎症、氧化应激和纤维化的常见疾病途径的激活。此外,多种药物对NAFLD和AF同时具有治疗作用,NAFLD和AF共同的发病机制可能成为未来潜在的治疗靶点。 Non-alcoholic fatty liver disease(NAFLD)and atrial fibrillation(AF)are common chronic noncommunicable diseases,and their incidence is on the rise.Many studies have confirmed that NAFLD is an independent risk factor for AF.However,due to the presence of confounding factors,the independent pathogenicity of NAFLD in the development of AF still needs further study.Mechanisms by which NAFLD induces AF include increased epicardial adipose tissue(EAT),myocardial remodeling,decreased adiponectin levels,and activation of common disease pathways that promote inflammation,oxidative stress,and fibrosis.In addition,multiple drugs have therapeutic effects on both NAFLD and AF,and the common pathogenesis of NAFLD and AF may become potential therapeutic targets in the future.
作者 邵宝兴 陈良华 SHAO Baoxing;CHEN Lianghua(Department of Cardiology,Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China)
出处 《山东第一医科大学(山东省医学科学院)学报》 CAS 2023年第10期790-796,共7页 Journal of Shandong First Medical University & Shandong Academy of Medical Sciences
关键词 非酒精性脂肪性肝病 心房颤动 心外膜脂肪 脂联素 nonalcoholic fatty liver disease atrial fibrillation epicardial fat tissue adiponectin
作者简介 邵宝兴,硕士研究生,研究方向:心房颤动,E-mail:2752512621@qq.com;通信作者:陈良华,博士,主任医师,研究方向:心房颤动,E-mail:m18766043870@163.com。
  • 相关文献

参考文献2

二级参考文献14

  • 1Mohamed H Ahmed,Christopher D Byrne.Obstructive sleep apnea syndrome and fatty liver: Association or causal link?[J].World Journal of Gastroenterology,2010,16(34):4243-4252. 被引量:8
  • 2Yu-Cheng Lin,Huey-Ming Lo,Jong-Dar Chen.Sonographic fatty liver, overweight and ischemic heart disease[J].World Journal of Gastroenterology,2005,11(31):4838-4842. 被引量:11
  • 3N Assy,I Bekirov,Y Mejritsky,L Solomon,S Szvalb,O Hussein.Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases[J].World Journal of Gastroenterology,2005,11(37):5834-5839. 被引量:4
  • 4Amedeo Lonardo,Silvia Lombardini,Federica Scaglioni,Stefano Ballestri,Anna Maria Verrone,Marco Bertolotti,Lucia Carulli,Dorval Ganazzi,Nicola Carulli,Paola Loria.Fatty liver,carotid disease and gallstones:A study of age-related associations[J].World Journal of Gastroenterology,2006,12(36):5826-5833. 被引量:15
  • 5Giuseppe Mancia,Robert Fagard,Krzysztof Narkiewicz,Josep Redon,Alberto Zanchetti,Michael B?hm,Thierry Christiaens,Renata Cifkova,Guy De Backer,Anna Dominiczak,Maurizio Galderisi,Diederick E. Grobbee,Tiny Jaarsma,Paulus Kirchhof,Sverre E. Kjeldsen,Stéphane Laurent,Athanasios J. Manolis,Peter M. Nilsson,Luis Miguel Ruilope,Roland E. Schmieder,Per Anton Sirnes,Peter Sleight,Margus Viigimaa,Bernard Waeber,Faiez Zannad,Josep Redon,Anna Dominiczak,Krzysztof Narkiewicz,Peter M. Nilsson.2013 ESH/ESC Guidelines for the management of arterial hypertension[J]. European Heart Journal . 2013 (28)
  • 6Derrick M. Van Rooyen,Lay T. Gan,Matthew M. Yeh,W. Geoffrey Haigh,Claire Z. Larter,George Ioannou,Narci C. Teoh,Geoffrey C. Farrell.Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome<!-- Doctopic: GMD -->[J].Journal of Hepatology.2013(1)
  • 7Marcello Ricardo Paulista Markus,Sebastian Edgar Baumeister,Jan Stritzke,Marcus D?rr,Henri Wallaschofski,Henry V?lzke,Wolfgang Lieb.Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population: The Study of Health in Pomerania (SHIP)[J].Arteriosclerosis Thrombosis and Vascular Biology.2013(7)
  • 8Matti J. Tikkanen,Rana Fayyad,Ole Faergeman,Anders G. Olsson,Chuan-Chuan Wun,Rachel Laskey,John J. Kastelein,Ingar Holme,Terje R. Pedersen.Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels[J].International Journal of Cardiology.2013
  • 9Giovanni Targher,Christopher D. Byrne.Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications[J].The Journal of Clinical Endocrinology & Metabolism.2013(2)
  • 10Lucia Carulli,Mauro Maurantonio,Lionel Hebbard,Enrica Baldelli,Paola Loria,Jacob George.Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD[J].Current Pharmaceutical Design.2013(29)

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部